Search Results for: chorea

Deutetrabenazine (Austedo)

The U.S. Food and Drug Administration (FDA) approved Austedo (deutetrabenazine) in 2017 for the treatment of chorea associated with Huntington’s disease (HD), according to a press release from its maker, Teva. Chorea is ... Read more